Follow-The-Filings

Security

ATOS

Atossa Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

2 owners 2 new 1 exit max 0.0% (Renaissance Technologies LLC)

grid → activity →
owners 2
max % 0.0%
tracked value $924
qoq N 2 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 109,007 $573 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% New 0.0% 66,739 $351 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 28,072 $17 hist

2 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$30.09M -$25.5M -$34.77M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $92.22M $74.46M $45.62M
Total non-current assets * $4.03M $1.99M $1.99M
Total assets $96.25M $76.44M $47.61M
Total current liabilities $5.24M $4.97M $8.26M
Total non-current liabilities * $0.00 $0.00 $0.00
Total equity $91.02M $71.48M $39.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$20.94M -$21.03M -$29.76M
Cash from investing -$14,000 -$19,000 -$23,000
Cash from financing -$1.48M $3.67M $0.00
Net change in cash -$22.43M -$17.38M -$29.78M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders

26Q1

period archive